A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

12.9K views

⸱

DOI:

10.3791/58929

⸱

January 20th, 2019

 ,  ,  ,  , 

In This Article

Summary

Using multi-step culture systems, we report an in vitro B cell to plasma cell differentiation model.

Abstract

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or mucosa and ensure humoral immunity. Due to their low frequency and location, the study of PCs is difficult in human. We reported a B to PC in vitro differentiation model using selected combinations of cytokines and activation molecules that allow to reproduce the sequential cell differentiation occurring in vivo. In this in vitro model, memory B cells (MBCs) will differentiate into pre-plasmablasts (prePBs), plasmablasts (PBs), early PCs and finally, into long-lived PCs, with a phenotype close to their counterparts in healthy individuals. We also built an open access bioinformatics tools to analyze the most prominent information from GEP data related to PC differentiation. These resources can be used to study human B to PC differentiation and in the current study, we investigated the gene expression regulation of epigenetic factors during human B to PC differentiation.

Introduction

The differentiation of B cells to plasma cells (PCs) is essential for humoral immunity and protect the host against infections1. B to PC differentiation is associated with major changes in transcription capacity and metabolism to accommodate to antibody secretion.The transcription factors that control B to PC differentiation have been extensively studied and revealed exclusive networks including B- and PC-specific transcription factors (TFs)2. In B cells, PAX5, BCL6 and BACH2 TFs are the guardians of B cell identity2,3. Induction of IRF4, PRDM1 ....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocol follows the guidelines in accordance with the Declaration of Helsinki and agreement of the Montpellier University Hospital Centre for Biological Resources.

1. In Vitro Normal Plasma Cell Differentiation Model

NOTE: PCs are generated through a four-step culture11,12,13.

  1. B cell amplification and differentiation
    1. Use peripheral blood cells from healthy volunteers for memory B cell purification.
    2. Dilute 7.5 mL of blood with 24.5 mL of RPMI 1640 m....

Access restricted. Please log in or start a trial to view this content.

Results

The overall procedure of in vitro normal PC differentiation is represented in Figure 1. Using the protocol presented here, we could generate adequate quantity of cells that could not be obtained with ex vivo human samples. Although the role of the complex network of transcription factors involved in PC differentiation has been investigated, the mechanisms regulating key PC differentiation transcription networks remain poorly known. Cellular differentiation is.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In human, PC are rare cells with differentiation stages taking place in anatomic places that hamper full biological characterization. We have developed an in vitro B to PC differentiation model using multi-step culture systems where various combinations of activation molecules and cytokines are subsequently applied in order to reproduce the sequential cell differentiation occurring in the different organs/tissues in vivo11,12,13.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose

Acknowledgements

This work was supported by grants from French INCA (Institut National du Cancer) Institute (PLBIO15-256), ANR (Tie-Skip) and ITMO Cancer (MM&TT).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
anti-CD2 magnetic beadsInvitrogen11159D
Anti-CD138-APCBeckman-Coulter B49219
Anti-CD19-APCBD555415
Anti-CD20-PBBeckman-Coulter B49208
Anti-CD27-PEBD555441
Anti-CD38-PEBeckman-Coulter A07779
Anti-histidineR&D SystemsMAB050
CpG ODN(PT)SigmaT*C*G*T*C*G*T*T*T*T*G*T*C*
G*T*T*T*T*G*T*C*G*T*T
human TransferinSigma-AldrichT3309
IFN-αMerckIntron A
IMDMGibco31980-022
Recombinan Human CD40L-hiR&D Systems2706-CL
Recombinant Human APRILR&D Systems5860-AP-010
Recombinant Human IL-10R&D Systems217-IL-
Recombinant Human IL-15Peprotech200-15-10ug
Recombinant Human IL-2 ProteinR&D Systems202-IL-
Recombinant Human IL-6Peprotech200-06

References

  1. Shapiro-Shelef, M., Calame, K. Regulation of plasma-cell development. Nature Reviews Immunology. 5 (3), 230-242 (2005).
  2. Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., Corcoran, L. M. The generation of antibody-secreting plasma cells. Nature Reviews Immunology. 15 (3), 160-17....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Plasma Cell DifferentiationCell PurificationFlow CytometryCytokine CocktailGene Expression ProfilingEpigenetic FactorsStromal Cell Conditioned MediumImmunoglobulin Secretion